Vascular endothelial growth factor-D over-expressing tumor cells induce differential effects on uterine vasculature in a mouse model of endometrial cancer

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Girling, Jane E ^a   Donoghue, Jacqueline F ^a   Lederman, Fiona L ^a   Cann, Leonie M ^a   Achen, Marc G ^b   Stacker, Steven A ^b   Rogers, Peter A W ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; ESTRADIOL; LYMPHATIC ENDOTHELIAL HYALURONAN RECEPTOR 1; PODOPLANIN; PROGESTERONE; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIUM CANCER; ENDOTHELIUM CELL; EPITHELIUM; ESTRUS CYCLE; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE RESPONSE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPHANGIOGENESIS; METASTASIS; MOUSE; MYOMETRIUM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA; TUMOR VASCULARIZATION; UTERINE BLOOD VESSEL; UTERUS BLOOD FLOW; ANIMAL; C57BL MOUSE; CELL CULTURE; DISEASE MODEL; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; TRANSGENIC MOUSE; UPREGULATION; UTERUS; VASCULARIZATION; XENOGRAFT;

MUS;

ANIMALS; CARCINOMA, ENDOMETRIOID; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 77955157603     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-84     Document Type: Article

References (57)

1. Girling JE, Rogers PA. Endometrial angiogenesis, arteriogenesis, and lymphangiogenesis. The Endometrium Molecular, Cellular, and Clinical Perspectives 2007, 88-104. London: Informa Healthcare, Aplin JD, Fazleabas AT, Glasser SR, Giudice LC, Second.
2. Rogers PA, Donoghue JF, Girling JE. Endometrial lymphangiogensis. Placenta 2008, 29(Suppl A):S48-54. 10.1016/j.placenta.2007.09.009, 17981324.
3. Rogers PA, Donoghue JF, Walter LM, Girling JE. Endometrial angiogenesis, vascular maturation, and lymphangiogenesis. Reprod Sci 2009, 16(2):147-151. 10.1177/1933719108325509, 19001552.
4. Donoghue JF, Lederman FL, Susil BJ, Rogers PA. Lymphangiogenesis of normal endometrium and endometrial adenocarcinoma. Hum Reprod 2007, 22(6):1705-1713. 10.1093/humrep/dem037, 17347164.
5. Stefansson IM, Salvesen HB, Akslen LA. Vascular proliferation is important for clinical progress of endometrial cancer. Cancer Res 2006, 66(6):3303-3309. 10.1158/0008-5472.CAN-05-1163, 16540684.
6. Yoshinaga K, Ito K, Moriya T, Nagase S, Takano T, Niikura H, Yaegashi N, Sato Y. Expression of vasohibin as a novel endothelium-derived angiogenesis inhibitor in endometrial cancer. Cancer Sci 2008, 99(5):914-919. 10.1111/j.1349-7006.2008.00777.x, 18325046.
7. Briet JM, Hollema H, Reesink N, Aalders JG, Mourits MJ, ten Hoor KA, Pras E, Boezen HM, van der Zee AG, Nijman HW. Lymphvascular space involvement: an independent prognostic factor in endometrial cancer. Gynecol Oncol 2005, 96(3):799-804. 10.1016/j.ygyno.2004.11.033, 15721428.
8. Mannelqvist M, Stefansson I, Salvesen HB, Akslen LA. Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma. Histopathology 2009, 54(2):174-183. 10.1111/j.1365-2559.2008.03201.x, 19207942.
9. Miyakuni Y, Matsumoto T, Arakawa A, Sonoue H, Suzuki C, Takeda S. Lymphatic invasion according to D2-40 immunostaining is a predictor of nodal metastasis in endometrioid adenocarcinoma of the uterine corpus. Pathol Int 2008, 58(8):471-476. 10.1111/j.1440-1827.2008.02258.x, 18705765.
10. O'Brien DJ, Flannelly G, Mooney EE, Foley M. Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality. BJOG 2009, 116(7):991-994. 10.1111/j.1471-0528.2009.02162.x, 19522800.
11. Achen MG, Stacker SA. Tumor lymphangiogenesis and metastatic spread-new players begin to emerge. Int J Cancer 2006, 119(8):1755-1760. 10.1002/ijc.21899, 16557570.
12. Achen MG, Stacker SA. Molecular control of lymphatic metastasis. Ann N Y Acad Sci 2008, 1131:225-234. 10.1196/annals.1413.020, 18519975.
13. Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, Eriksson U, Alitalo K. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol 1997, 173(2):211-215. 10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO;2-H, 9365524.
14. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997, 16(13):3898-3911. 10.1093/emboj/16.13.3898, 1170014, 9233800.
15. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008, 3:367-397. 10.1146/annurev.pathmechdis.3.121806.151515, 18039141.
16. McColl BK, Baldwin ME, Roufail S, Freeman C, Moritz RL, Simpson RJ, Alitalo K, Stacker SA, Achen MG. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med 2003, 198(6):863-868. 10.1084/jem.20030361, 2194198, 12963694.
17. McColl BK, Paavonen K, Karnezis T, Harris NC, Davydova N, Rothacker J, Nice EC, Harder KW, Roufail S, Hibbs ML, Rogers PA, Alitalo K, Stacker SA, Achen MG. Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J 2007, 21(4):1088-1098. 10.1096/fj.06-7060com, 17242158.
18. Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chretien M, Seidah NG, Khatib AM. The secretory proprotein convertases convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 2003, 111(11):1723-1732. 10.1172/JCI17220, 156106, 12782675.
19. Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, Roufail S, Simpson RJ, Moritz R, Karpanen T, Alitalo K, Achen MG. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 1999, 274(45):32127-32136. 10.1074/jbc.274.45.32127, 10542248.
20. Baldwin ME, Stacker SA, Achen MG. Molecular control of lymphangiogenesis. Bioessays 2002, 24(11):1030-1040. 10.1002/bies.10173, 12386934.
21. Baldwin ME, Catimel B, Nice EC, Roufail S, Hall NE, Stenvers KL, Karkkainen MJ, Alitalo K, Stacker SA, Achen MG. The specificity of receptor binding by vascular endothelial growth factor-d is different in mouse and man. J Biol Chem 2001, 276(22):19166-19171. 10.1074/jbc.M100097200, 11279005.
22. Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, Kubo H, Stacker SA, Achen MG. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 2005, 25(6):2441-2449. 10.1128/MCB.25.6.2441-2449.2005, 1061605, 15743836.
23. Haiko P, Makinen T, Keskitalo S, Taipale J, Karkkainen MJ, Baldwin ME, Stacker SA, Achen MG, Alitalo K. Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol 2008, 28(15):4843-4850. 10.1128/MCB.02214-07, 2493372, 18519586.
24. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholova I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Ylä-Herttuala S. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 2003, 92(10):1098-1106. 10.1161/01.RES.0000073584.46059.E3, 12714562.
25. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001, 7(2):186-191. 10.1038/84635, 11175849.
26. Van Trappen PO, Pepper MS. Lymphangiogenesis in human gynaecological cancers. Angiogenesis 2005, 8(2):137-145. 10.1007/s10456-005-9008-7, 16211357.
27. Yokoyama Y, Charnock-Jones DS, Licence D, Yanaihara A, Hastings JM, Holland CM, Emoto M, Sakamoto A, Sakamoto T, Maruyama H, Sato S, Mizunuma H, Smith SK. Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma. Clin Cancer Res 2003, 9(4):1361-1369.
28. Girling JE, Lederman FL, Walter LM, Rogers PA. Progesterone, but not estrogen, stimulates vessel maturation in the mouse endometrium. Endocrinology 2007, 148(11):5433-5441. 10.1210/en.2007-0856, 17690161.
29. Heryanto B, Girling JE, Rogers PA. Intravascular neutrophils partially mediate the endometrial endothelial cell proliferative response to oestrogen in ovariectomised mice. Reproduction 2004, 127(5):613-620. 10.1530/rep.1.00161, 15129017.
30. Heryanto B, Lipson KE, Rogers PA. Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse. Reproduction 2003, 125(3):337-346. 10.1530/rep.0.1250337, 12611597.
31. Walter LM, Rogers PA, Girling JE. The role of progesterone in endometrial angiogenesis in pregnant and ovariectomised mice. Reproduction 2005, 129(6):765-777. 10.1530/rep.1.00625, 15923392.
32. Hashii K, Tohya K, Kimura M, Tateyama I, Mori T, Kadota E, Hashimoto S, Tomura T. Novel animal model of lymph node metastasis by intrauterine inoculation of the actively metastatic subline PL3 separated from rat Walker 256 tumor cells. Invasion Metastasis 1997, 17(3):149-157.
33. Koukourakis MI, Giatromanolaki A, Sivridis E, Simopoulos C, Gatter KC, Harris AL, Jackson DG. LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer. J Clin Pathol 2005, 58(2):202-206. 10.1136/jcp.2004.019174, 1770560, 15677543.
34. Red-Horse K, Rivera J, Schanz A, Zhou Y, Winn V, Kapidzic M, Maltepe E, Okazaki K, Kochman R, Vo KC, Giudice L, Erlebacher A, McCune JM, Stoddart CA, Fisher SJ. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J Clin Invest 2006, 116(10):2643-2652. 1570373, 16998586.
35. Fabian G. The lymphatic vessels of the uterus during the sexual cycles of the mice. Lymphology 1976, 9(2):78-82.
36. Head JR, Billingham RE. Concerning the immunology of the uterus. Am J Reprod Immunol 1986, 10(3):76-81.
37. Hoggan G, Hoggan FE. On the comparative anatomy of the lymphatics of the uterus. J Anat 1881, 16:50-89.
38. Lauweryns JM, Cornillie FJ. Topography and ultrastructure of the uterine lymphatics in the rat. Eur J Obstet Gynecol R B 1984, 18(5-6):309-327.
39. McLean JM, Scothorne RJ. The lymphatics of the endometrium in the rabbit. J Anat 1970, 107(Pt 1):39-48. 1234163, 5473292.
40. Uchino S, Ichikawa S, Okubo M, Nakamura Y, Iimura A. Methods of detection of lymphatics and their changes with oestrous cycle. Int Angiol 1987, 6(3):271-278.
41. Byzova TV, Goldman CK, Jankau J, Chen J, Cabrera G, Achen MG, Stacker SA, Carnevale KA, Siemionow M, Deitcher SR, DiCorleto PE. Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 2002, 99(12):4434-4442. 10.1182/blood.V99.12.4434, 12036873.
42. Kholova I, Koota S, Kaskenpaa N, Leppanen P, Narvainen J, Kavec M, Rissanen TT, Hazes T, Korpisalo P, Grohn O, Ylä-Herttuala S. Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle. Hum Gene Ther 2007, 18(3):232-244. 10.1089/hum.2006.100, 17362136.
43. Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001, 20(6):1223-1231. 10.1093/emboj/20.6.1223, 145532, 11250889.
44. Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivela A, Hedman A, Hedman M, Heikura T, Orden MR, Stacker SA, Achen MG, Hartikainen J, Ylä-Herttuala S. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 2004, 109(8):1029-1035. 10.1161/01.CIR.0000115519.03688.A2, 14967735.
45. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, Ylä-Herttuala S, Jackson DG, Alitalo K, McDonald DM. Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 2005, 115(2):247-257. 544601, 15668734.
46. Engelsen IB, Akslen LA, Salvesen HB. Biologic markers in endometrial cancer treatment. APMIS 2009, 117(10):693-707. 10.1111/j.1600-0463.2009.02467.x, 19775337.
47. Stefansson IM, Salvesen HB, Immervoll H, Akslen LA. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type. Histopathology 2004, 44(5):472-479. 10.1111/j.1365-2559.2004.01882.x, 15139995.
48. Cursiefen C, Chen L, Saint-Geniez M, Hamrah P, Jin Y, Rashid S, Pytowski B, Persaud K, Wu Y, Streilein JW, Dana R. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA 2006, 103(30):11405-11410. 10.1073/pnas.0506112103, 1544098, 16849433.
49. Albuquerque RJ, Hayashi T, Cho WG, Kleinman ME, Dridi S, Takeda A, Baffi JZ, Yamada K, Kaneko H, Green MG, Chappell J, Wilting J, Weich HA, Yamagami S, Amano S, Mizuki N, Alexander JS, Peterson ML, Brekken RA, Hirashima M, Capoor S, Usui T, Ambati BK, Ambati J. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 2009, 15(9):1023-1030. 10.1038/nm.2018, 2882165, 19668192.
50. Dunk C, Ahmed A. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast. Histol Histopathol 2001, 16(2):359-375.
51. Mints M, Blomgren B, Palmblad J. Expression of vascular endothelial growth factor receptor-3 in the endometrium in menorrhagia. Int J Mol Med 2007, 19(6):909-913.
52. Vuorela P, Carpen O, Tulppala M, Halmesmaki E. VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol Hum Reprod 2000, 6(3):276-282. 10.1093/molehr/6.3.276, 10694277.
53. Benest AV, Harper SJ, Herttuala SY, Alitalo K, Bates DO. VEGF-C induced angiogenesis preferentially occurs at a distance from lymphangiogenesis. Cardiovasc Res 2008, 78(2):315-323. 10.1093/cvr/cvm094, 2613351, 18065770.
54. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997, 276(5317):1423-1425. 10.1126/science.276.5317.1423, 9162011.
55. Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yla-Herttuala S, Jaattela M, Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 2001, 61(5):1786-1790.
56. Lohela M, Bry M, Tammela T, Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 2009, 21(2):154-165. 10.1016/j.ceb.2008.12.012, 19230644.
57. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol 2006, 7(5):359-371. 10.1038/nrm1911, 16633338.